Dr. Sebastian Foertsch, Senior Scientist from iff will talk about Biodegradability in Pharma. We will discuss why biodegradability is a desirable feature for many products and why it is also relevant in Pharma. Moreover, biodegradability analyses will be discussed.
In addition to Dr. Sebastian Foertsch's about Biodegradability in Pharma, @Paul Giffen frrom AstraZeneca will talk briefly about the ECHA proposal to ban all PFAS molecules. ECHA has taken a blanket approach to classification of PFAS (any molecule with a CF3 motif) arguing that all result in environmental accumulation of toxic trifluoracetic acid in water/soil, etc., and leading to human health issues. They, therefore, classify all PFAS as persistent, bio-accumulative, and toxic. We will be scheduling our next meeting on this topic.
------------------------------
Allison Radwick Ph.D.
Sr Regulatory & Policy Comms Mgr
USP
Rockville MD
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------